Rnaz stock forecast.
September 26, 2023. in News. Reading Time: 3 mins read. A A. 0. On September 26, 2023, the stock of Transcode Therapeutics (RNAZ) experienced a significant decline of nearly 70%. This decline can be attributed to the company’s decision to price its public offering at $0.51 per share, resulting in an $8 million offering of 15.7 million shares.
Stock Price Forecast. The 2 analysts offering 12-month price forecasts for Vistagen Therapeutics Inc have a median target of 12.00, with a high estimate of 12.00 and a low estimate of 12.00.Forecast . Price target. 3.00 0.00 0.00%. The 1 analyst offering 1 year price forecasts for RNAZ have a max estimate of — and a min estimate of —. Analyst rating. Based on 1 analyst giving stock ratings to RNAZ in the past 3 months. EPS. Annual Annual Quarterly Quarterly More MoreIf we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended RNAZ as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. TransCode Therapeutics Inc is expected to report earnings per share of -$1.09 for the current quarter.Dec 1, 2023 · Stock Price Forecast. According to 1 stock analyst, the 12-month stock price forecast for Guardforce AI stock is $14, which predicts an increase of 294.37%. On average, analysts rate Guardforce AI stock as a strong buy. TransCode Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. RNAZ updated stock price target summary.
RNAZ and CRDO are leading our lists this morning. By William White, InvestorPlace Writer Feb 15, 2023, 7:32 am EDT. We’re covering the biggest pre-market stock movers for Wednesday! That ...High growth companies in the Pharmaceuticals-biotech industry. View Past Performance. Discover TransCode Therapeutics' earnings and revenue growth rates, forecasts, and the latest analyst predictions while comparing them to its industry peers.Track TransCode Therapeutics Inc (RNAZ) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors
On October 31, 2023, RNAZ stock showed some interesting movements in the market. The stock had a previous close of $0.36 and opened at $0.39. Throughout the day, it traded within a range of $0.37 to $0.42. The volume for the day was 283,321 shares, which is significantly lower than the average volume of 4,101,996 shares over the past three months.
Nov 29, 2023 · Vallon Pharmaceuticals' stock was trading at $8.70 on January 1st, 2023. Since then, VLON shares have decreased by 93.0% and is now trading at $0.6080. View the best growth stocks for 2023 here. What this means: InvestorsObserver gives Transcode Therapeutics Inc (RNAZ) an overall rank of 30, which is below average. Transcode Therapeutics Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 30 means that 70% of stocks appear more favorable to our system.View live TransCode Therapeutics, Inc. chart to track its stock's price action. Find market predictions, RNAZ financials and market news. RNAZ : 0.2620 (+0.77%) Positive Results Causes Pop In Biotech Stock Yolowire - Wed Oct 26, 2022. A Boston-based %Biotech company really captured the attention of traders on Wednesday after the it reported Positive Preclinical Results with its Lead Candidate, TTX-MC138, in Pancreatic Adenocarcinoma....Discussions. Forecast. Stock Split. Transcode TherapeuticsCommon Stock (RNAZ) current stock price is $0.324, accompanied by a 24-hour trading volume of 72,711. The stock experienced an increase of +0.62% in the last 24 hours and a decline by -24.97% in the past month. Looking at the chart, RNAZ stock price is below the pivot point level of …
Nov 1, 2023 · According to analyst projections, RNAZ’s forecast low is $3.00 with $3.00 as the target high. To hit the forecast high, the stock’s price needs a -733.33% plunge from its current level, while the stock would need to soar -733.33% for it to hit the projected low. TransCode Therapeutics Inc (RNAZ) estimates and forecasts
Find the latest analyst research for TransCode Therapeutics, Inc. Common Stock (RNAZ) at ... Forecast Changes; ... Analysts evaluate the stock’s expected performance in a given time ...
TransCode Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. RNAZ updated stock price target summary.Dec 1, 2023 · Stock Price Forecast. According to 1 stock analyst, the 12-month stock price forecast for Guardforce AI stock is $14, which predicts an increase of 294.37%. On average, analysts rate Guardforce AI stock as a strong buy. According to analyst projections, RNAZ’s forecast low is $3.00 with $3.00 as the target high. To hit the forecast high, the stock’s price needs a -733.33% plunge from its current level, while the stock would need to soar -733.33% for it to hit the projected low. TransCode Therapeutics Inc (RNAZ) estimates and forecastsTransCode Therapeutics Stock Forecast. Is TransCode Therapeutics Stock Undervalued? The current TransCode Therapeutics [ RNAZ] share price is $0.23. The Score for RNAZ is 9, which is 82% below its historic median score of 50, and infers higher risk than normal. RNAZ is currently trading in the 0-10% percentile range relative to its historical ... The stock has garnered positive attention from analysts, with a median target price of $12.00, representing a potential increase of 294.74% from its last price of $3.04. The 12-month price forecasts provided by one analyst for RNAZ stock have a high estimate, low estimate, and median estimate all set at $12.00.Find the latest historical data for TransCode Therapeutics, Inc. Common Stock (RNAZ) at Nasdaq.com. ... Forecast Changes; Commodities. Gold; ... Get up to 10 years of daily historical stock prices ...
While only two analysts cover RNAZ stock according to TipRanks, they are incredibly bullish on its prospects. Both experts forecast shares hitting $12 , translating to over 400% upside, even with ...Stock Price Forecast. The 2 analysts offering 12-month price forecasts for Phaxiam Therapeutics SA have a median target of 10.70, with a high estimate of 12.17 and a low estimate of 9.24.The TransCode Therapeutics, Inc. stock price gained 6.25% on the last trading day (Wednesday, 22nd Nov 2023), rising from $0.230 to $0.245. During the last trading day the stock fluctuated 13.64% from a day low at $0.220 to a day high of $0.250. The price has fallen in 7 of the last 10 days and is down by -36.25% for this period.Get The Latest FSRDQ Stock Analysis, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat. Skip to main content. S&P 500 4,567.80. DOW 35,950.89. QQQ 388.83. Are blue chip stocks a good investment? Trading Experts Call It “The Perfect Tesla Trade” (Ad)Oct 31, 2023 · Transcode Therapeutics Inc (RNAZ) $0.42 0.05 (12.13%) 16:00 EDT RNAZ Stock Quote Delayed 30 Minutes. While only two analysts cover RNAZ stock according to TipRanks, they are incredibly bullish on its prospects. Both experts forecast shares hitting $12, translating to over 400% upside, even with ...
Find the latest AgriFORCE Growing Systems Ltd. (AGRI) stock quote, history, news and other vital information to help you with your stock trading and investing.
Throughout the U.S., the weather can be quite unpredictable, even with state-of-the-art radar, sensors and computer modeling technology right at meteorologists’ fingertips. The Old Farmer’s Almanac first provided valuable statistics and dat...TNON’s penny stock status may be part of the reason for the rise. Tenon Medical (NASDAQ: TNON) stock is taking off on Wednesday morning despite a lack of news from the medical device company ...Discover historical prices for RNAZ stock on Yahoo Finance. View daily, weekly or monthly format back to when TransCode Therapeutics, Inc. stock was issued. Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Salarius Pharmaceuticals Inc have a median target of 3.25, with a high estimate of 3.25 and a low estimate of 3.25. The ...Find real-time PHXM - Phaxiam Therapeutics SA stock quotes, company profile, news and forecasts from CNN Business.RNAZ stock forecast . Since RNAZ is a newly listed company with a market cap of only about $50 million, none of the analysts are covering the stock. The forecast for RNAZ will eventually depend on ...Oct 18, 2023 · If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended RNAZ as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. TransCode Therapeutics Inc is expected to report earnings per share of -$1.09 for the current quarter.
You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a broker to begin trading.
TransCode Therapeutics Inc (NASDAQ: RNAZ)’s stock price has decreased by -16.45 compared to its previous closing price of 0.26. However, the company has seen a -32.02% decrease in its stock price over the last five trading sessions. InvestorPlace reported 2023-10-27 that TransCode Therapeutics (NASDAQ: RNAZ ) stock is taking a …
RNAZ stock has been on a downward trend ever since announcing its proposed public stock offering at the start of the month. With today’s news, the company’s shares are up 100.5% in pre-market ...Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.Find the latest TransCode Therapeutics, Inc. RNAZ analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range investment ratingBOSTON, Nov. 14, 2023 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using …Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Salarius Pharmaceuticals Inc have a median target of 3.25, with a high estimate of 3.25 and a low estimate of 3.25. The ...View TransCode Therapeutics Inc RNAZ investment & stock information. Get the latest TransCode Therapeutics Inc RNAZ detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Analyst Ratings of TRANSCODE THERAPEUTICS INC(NASDAQ:RNAZ) stock. Analyst ratings, forecast, price target, upgrades and downgrades. login register. Home; ... ChartMill assigns a Buy % Consensus number of 83% to RNAZ. ... Analysts have set a mean price target forecast of 3.06. This target is 850.31% above the current price.According to our current RNAZ stock forecast, the value of TransCode Therapeutics, Inc. shares will drop by -6.78% and reach $ 0.232128 per share by …Dec 4, 2023 · The RNAZ stock price is -10536.36% off its 52-week high price of $23.40 and 31.82% above the 52-week low of $0.15. If we look at the company’s 10-day average daily trading volume, we find that it stood at 4.59 million shares traded. The 3-month trading volume is 6.95 million shares. The consensus among analysts is that TransCode Therapeutics ...
1 analysts have issued 1 year target prices for TransCode Therapeutics' stock. Their RNAZ share price targets range from $12.00 to $12.00. On average, they expect the company's share price to reach $12.00 in the next twelve months. This suggests a possible upside of 5,379.5% from the stock's current price.See the latest TransCode Therapeutics Inc stock price (RNAZ:XNAS), related news, valuation, dividends and more to help you make your investing decisions.RNAZ | AI Stock Analysis for TransCode Therapeutics Inc RNAZ Including Stock Price, Stock Chart, Technical, Fundamental, Sentiment Analysis and More. Start now and save 50% for the first 3 months save 50% for the first 3 months. Ticker. Company. Your search produced no matches.The U.S. National Weather Service (NWS) is a part of the National Oceanic and Atmospheric Administration (NOAA). Many people rely on the National Weather Service’s forecasts in order to better anticipate what the weather will be like so the...Instagram:https://instagram. best bank to open an account in michiganyerbfai c3 stock pricepc for trading Find real-time RNAZ - Transcode Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. lucid midnight dream editionhow to buy aramco shares Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you. usb stoc The U.S. National Weather Service (NWS) is a part of the National Oceanic and Atmospheric Administration (NOAA). Many people rely on the National Weather Service’s forecasts in order to better anticipate what the weather will be like so the...Find real-time SCLX - Scilex Holding Co stock quotes, company profile, news and forecasts from CNN Business.09/25/2023 - 08:01 PM. BOSTON, Sept. 25, 2023 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ), (the “Company”), an RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced the pricing of its underwritten public offering of an aggregate of 15,700,000 …